Cover Image

The HIV-1 antisense transcript AST is an inducer of viral latency

Saved in:

Bibliographic Details
Main Authors:	F. Romerio (Author), J.C. Zapata (Author), F. Kashanchi (Author), S. Iordanskyi (Author)
Format:	Book
Published:	Elsevier, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The HIV-1 antisense transcript AST recruits the polycomb repressor complex 2 to the HIV-1 5'LTR and acts as a viral latency factor
by: F. Romerio, et al.
Published: (2017)

PP 1.28 - 00156 The HIV-1 antisense RNA Ast promotes viral latency via epigenetic silencing of the proviral 5'LTR and is expressed in latently infected cells from ART-suppressed donors
by: F. Romerio, et al.
Published: (2022)

Lack of transcriptional latency in infected primary cells in the presence of exosomes and cART
by: C. DeMarino, et al.
Published: (2017)

Detection and enrichment to near purity of rare HIV-1 infected cells by PrimeFlow RNA
by: F. Romerio, et al.
Published: (2015)

HIV-1 transcriptional latency in resting CD4 T-cell
by: M. Benkirane
Published: (2015)

Gut and blood differ in mechanisms governing HIV transcription/latency
by: S. Telwatte, et al.
Published: (2017)

Low viral reservoir treated individuals show unusual HIV latency distribution
by: C. Gálvez, et al.
Published: (2019)

Interactions with pathogenic bacteria induce HIV-1 latency in macrophages through altered transcription factor recruitment to the LTR
by: T. Hanley, et al.
Published: (2019)

In-depth transcription profile comparison of multiple primary cell HIV latency models
by: S. Moron-Lopez, et al.
Published: (2019)

PP 1.4 - 00037 Histone decrotonylation uniquely regulates HIV-1 transcription and can be modulated to control HIV-1 latency
by: T.L. Simermeyer, et al.
Published: (2022)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

Tissue-specific effects of latency-reversing agents on HIV transcriptional blocks in gut and blood
by: S. Telwatte, et al.
Published: (2019)

DNA-PK regulates HIV transcription and latency by supporting the activity of RNA polymerase II and the recruitment of transcription machinery at HIV LTR
by: M. Tyagi, et al.
Published: (2017)

OP 1.5 - 00046 P400/Tip60 chromatin remodeling complex in HIV transcription and latency establishment
by: L. Mori, et al.
Published: (2022)

HIV persistence in lymph nodes from virally suppressed individuals: residual production VS latency
by: M. Pardons, et al.
Published: (2017)

10 The interferon-inducible restriction factor TRIM22 contributes to HIV-1 latency
by: F. Turrini, et al.
Published: (2016)

Comprehensive expressional analyses of antisense transcripts in colon cancer tissues using artificial antisense probes
by: Kanai Akio, et al.
Published: (2011)

Antisense Oligonucleotide-Based Therapy of Viral Infections
by: Woan-Yuh Tarn, et al.
Published: (2021)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

Galectin-1 promotes HIV-1 latency reactivation
by: J. Rubione, et al.
Published: (2019)

HIV-1 Transcription Inhibition Using Small RNA-Binding Molecules
by: Pooja Khatkar, et al.
Published: (2023)

20 Sirtuin1 inhibitor nicotinamide disrupts HIV-1 latency
by: S. Samer, et al.
Published: (2016)

LncRNA Nqo1-AS1 Attenuates Cigarette Smoke-Induced Oxidative Stress by Upregulating its Natural Antisense Transcript Nqo1
by: Haiyun Zhang, et al.
Published: (2021)

Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 Transcript
by: Loren L. Flynn, et al.
Published: (2018)

Histone deacetylase inhibitors induce transcription of unspliced but not multiply spliced HIV-1 RNA from proviral genomes during latency reversal, affecting antigen presentation and detection by CD8+ T cells
by: T. Mota, et al.
Published: (2019)

Influence of SULT1A1&ast;2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients
by: Chamnanphon M, et al.
Published: (2021)

Novel use of alprazolam as a potential HIV-1 latency reversing agent
by: W. Elbezanti, et al.
Published: (2017)

Visualisation of HIV reactivation from latency in primary resting memory T-cells
by: F. Kizito, et al.
Published: (2019)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019)

An Antisense Oligonucleotide Leads to Suppressed Transcription of Hdac2 and Long-Term Memory Enhancement
by: Shane G. Poplawski, et al.
Published: (2020)

PP 1.25 - 00136 Daily Variations in Residual Viral Transcription in ART-Treated People Living with HIV-1
by: A. Fert, et al.
Published: (2022)

Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion Transcripts
by: Neetha Nanoth Vellichirammal, et al.
Published: (2020)

Block or degrade? Balancing on- and off-target effects of antisense strategies against transcripts with expanded triplet repeats in DM1
by: Najoua El Boujnouni, et al.
Published: (2023)

PP 2.8 - 00124 Spironolactone Represses HIV-1 Driven Transcription in Human Microglia and T cell Models of Latency and Alters DNA Methylation of Metabolic Genes
by: A. Pang, et al.
Published: (2022)

PP 5.4 - 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents
by: L. Pache, et al.
Published: (2022)

Mannosylated PAMAM G2 dendrimers mediated rate programmed delivery of efavirenz target HIV viral latency at reservoirs
by: Rohini Kharwade, et al.
Published: (2024)

The unique enrichment of histone modifications and its relationship with HIV-1 latency in some chromosomes
by: K.C. Kim, et al.
Published: (2015)

Developing an in vitro model for HIV-1 latency in Tfh cells using tonsillar tissue
by: B. Luttge, et al.
Published: (2017)

Latency reactivating agents: impact on human macrophages physiology and susceptibility to HIV-1 infection
by: L. Hany, et al.
Published: (2019)

Shining the RNA-Seq microscope on models of HIV latency
by: C.H. Woelk, et al.
Published: (2015)